Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-056566)

Filing Details

Accession Number:: 0001144204-13-056566
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-23 21:32:37
Reporting Period:: 2013-10-21

Filing Date:: 2013-10-23
Accepted Time:: 2013-10-23 21:32:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1270073	Intercept Pharmaceuticals Inc	ICPT	Pharmaceutical Preparations (2834)	223868459

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559515	S.p.a. Genextra	Via G. De Grassi, 11 Milan L6 20123		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2013-10-21	124,912	$62.50	5,938,890	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares of common stock sold under a registration statement on Form S-1 (File No. 333-191501) by Genextra S.p.A. to the underwriter on October 21, 2013 pursuant to the underwriter's partial exercise of its over-allotment option.